Rani Therapeutics declared its shelf registration effective and listed on the American electronic stock exchange.
2 reports, 2 independent
Updated May 26
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Rani Therapeutics declared its shelf registration effective and listed on the American electronic stock exchange.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Rani Therapeutics completed its shelf registration and listing on Nasdaq.1 source
SEC declared Compass Therapeutics' shelf registration effective, with Ladenburg Thalmann as co-manager.1 source
Keep exploring
The entities involved
-
Securities and Exchange Commission
government agency of the Philippines
-
Nasdaq
American fully electronic stock exchange
-
Ladenburg Thalmann
American financial services company
Nothing else this week.
Related events
- Vistra filed a shelf registration statement with the Securities and Exchange Commission on September 11, 2026.
- The SEC declared a registration statement effective for a company, which trades securities on the NASDAQ Global Market.
- Elutia is trading on the Nasdaq stock exchange and requires regulatory clearance from the FDA for product launches.
Coverage
Newest first; wire copies grouped- manilatimes.net
- GlobeNewswireCompass Therapeutics Announces Pricing of Upsized $120 Million Public Offering BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncol